EMPRELVIA
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Nov 2020)
What this means for you
This application is over — abandoned 02 Nov 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88381543
- Mark type
- Stylized text
- Filed
- 11 Apr 2019
- Published for opposition
- 06 Aug 2019
- Abandoned
- 02 Nov 2020
- Attorney of record
- Jeffrey J. Ellison
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and cystic fibrosis
Owner
- Corbus Pharmaceuticals, Inc., Norwood, MA, US
- Corbus Pharmaceuticals, Inc., Norwood, MA, US
Prosecution history
- 02 Nov 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Nov 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Apr 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2020 — SOU EXTENSION 1 GRANTED
- 01 Apr 2020 — SOU EXTENSION 1 FILED
- 01 Apr 2020 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Aug 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2019 — PUBLISHED FOR OPPOSITION
- 17 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jun 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jun 2019 — ASSIGNED TO EXAMINER
- 29 Apr 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED